Biotech 365

Main menu

Skip to primary content
Skip to secondary content
  • Biotech 365
  • Biotech Companies
    • Biotech Crowdfunding
    • Biotech Investors
    • Biotech Companies
    • Biotech companies Database
  • BioLeads
  • BioMarketplace
  • Biotech Jobs
  • Biopharma News
  • Offers
  • Contact

Tag Archives: Anne-Marie GRAFFIN

Valneva – innovative vaccines against infectious diseases

Posted on 2015-01-17 by Biotech365

Valneva is a biotech company covering the full value chain from bench to market on innovative vaccines against infectious diseases.

Valneva – innovative vaccines against infectious diseases

valneva

Continue reading →

Posted in Biotech Companies, Biotech Companies Austria, Biotech Companies France, Biotech Companies Japan, Biotech Companies UK, Biotech Companies USA | Tagged Alain MUNOZ, Alexander VON GABAIN, Anne-Marie GRAFFIN, Clostridium difficile, EB66, EB66 vaccine production cell line, Franck GRIMAUD, Frédéric GRIMAUD, Hans WIGZELL, IC31, IC31 adjuvant, infectious disease, infectious diseases, innovative vaccine, innovative vaccine against infectious disease, innovative vaccines against infectious diseases, Intercell, IXIARO, James SULAT, Japanese encephalitis, Japanese encephalitis virus, Japanese encephalitis virus infection, JESPECT, Lyme Borreliosis, Michel GRÉCO, prevention Japanese encephalitis, Pseudomonas aeruginosa, Reinhard KANDERA, Thomas LINGELBACH, Valneva, Valneva - innovative vaccines against infectious diseases, virus infection, Vivalis

Follow Biotech 365 !

Follow @Biotech365

Newsletter

Search on Biotech 365 :

Search for Protocols :

Search on PubMed :

                      About us                       Terms                       Partners                       Contact                       Offers                       RSS feed - Biotech 365                      
Proudly powered by WordPress